MAPK3 and Schnyder corneal dystrophy: MEK-dependent ERK1/2 signaling inactivation clearly not only reduced SSRBC adhesion and vascular blockade but also decreased SSRBC trapping in organs typically affected in SCD, including the spleen, liver and lungs.